Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-1.11%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-1.11%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
2.1
3.87%
20%
—
-101.79%
Never
—
5 Years
Score2.1
Net Growth3.87%
Net Trend20%
Net Income Consistency—
Rev Growth-101.79%
Rev TrendNever
Revenue Consistency—
Aptevo Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 4M to $ 0.00 and net income went from -$ 17M to -$ 25M. Revenue increased in 0 of those 5 years; net income in 1.
Across Aptevo Therapeutics Inc's full reported history, from 2016 to 2025, revenue declined from $ 36M to $ 0.00 and net income went from -$ 112M to -$ 25M. Revenue increased in 30% of the years measured; net income in 40%.
Aptevo Therapeutics Inc currently holds a 5-year HDB Score of 2.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 3.40 | — |
1 Year2025-08-13 | $ 34.38 | -90.11% |
5 Years2021-08-13 | $ 1000K | -100.00% |
10 Years2016-08-12 | $ 1000K | -100.00% |
All Time2016-07-20 | $ 1000K | -100.00% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | 10 Years2016-08-12 | All Time2016-07-20 |
|---|---|---|---|---|---|
| Price | $ 3.40 | $ 34.38 | $ 1000K | $ 1000K | $ 1000K |
| Return | — | -90.11% | -100.00% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | -$ 220K | -$ 26M | $ 14M |
| 2025 | $ 0.00 | -$ 25M | $ 21M |
| 2024 | $ 0.00 | -$ 24M | $ 8M |
| 2023 | $ 0.00 | -$ 17M | $ 16M |
| 2022 | $ 3M | $ 8M | $ 22M |
| 2021 | $ 12M | -$ 27M | $ 45M |
| 2020 | $ 4M | -$ 17M | $ 39M |
| 2019 | $ 32M | -$ 44M | $ 12M |
| 2018 | $ 23M | -$ 53M | $ 30M |
| 2017 | $ 14M | $ 6M | $ 80M |
| IPO2016 | $ 36M | -$ 112M | $ 54M |
Explore beyond APVO
You're looking at Aptevo Therapeutics Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
